Academia & Research Institutes
The analysis and validation your grant depends on
An industrial-grade partner for the work your core facility cannot schedule - with grant-aligned timelines, co-funding structures where they exist, and co-authorship where we have earned it.
What we hear
What we hear from principal investigators and centre directors
- More data generated than can be analysed, and deliverables approaching
- Translational ambitions blocked by no route to assay development or manufacturing
- Core facilities over-subscribed exactly when the work is needed
- Funding structures that make conventional vendor contracting awkward
What we do about it
One workstream, one accountable lead
We work inside the way research is actually funded. We can be written into grant applications as the named industry partner, we structure quotes to fit funding rules and calendars, and in markets with public co-funding - Canada in particular - we help you use it.
Services
Most relevant services
Academic pricing
Academic and consortium pricing applies to platform subscriptions and analytics framework agreements. Typical projects run USD 25K–300K; consortium platform agreements sit at the upper end and cover multiple groups or campuses.
On authorship and IP
Where we have made a genuine scientific contribution and you want us as co-authors, we are glad to be. Where the work is service delivery, we expect acknowledgement, not authorship. Data and results from your grant remain yours.
Proof
What it looks like in practice
A 480-sample multi-omics cohort analysed and reduced to a six-marker panel validated at AUC 0.89 in an independent cohort - grant deliverables met three months early, joint publication submitted.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.